COVID-19 Outbreak-Global Temozolomide Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Published on 12/01/2020| Code: MAR41115D| Category: Utilities| Total Pages: 110

Temozolomide (TMZ; brand names Temodar and Temodal and Temcad) is an oral chemotherapy drug. It is an alkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme

The Temozolomide market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Temozolomide industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Temozolomide market can be split based on product types, major applications, and important countries as follows:

Key players in the global Temozolomide market covered in Chapter 12:

Tianjin Tasly
Merck
Jianyuan
Ind-Swift
Chongqing Lummy
Miracalus
Panacea
Celon
Macleods
Lunarsun
Natco
Fulford
Cipla

In Chapter 4 and 14.1, on the basis of types, the Temozolomide market from 2015 to 2025 is primarily split into:

Temozolomide Capsules
Temozolomide Injection

In Chapter 5 and 14.2, on the basis of applications, the Temozolomide market from 2015 to 2025 covers:

Hospitals
Clinics
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Temozolomide Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Temozolomide

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Temozolomide industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global Temozolomide Market Size, 2015 – 2020

2.1.2 Global Temozolomide Market Size by Type, 2015 – 2020

2.1.3 Global Temozolomide Market Size by Application, 2015 – 2020

2.1.4 Global Temozolomide Market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on Temozolomide Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of Temozolomide Analysis

3.2 Major Players of Temozolomide

3.3 Temozolomide Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of Temozolomide

3.3.3 Labor Cost of Temozolomide

3.4 Market Distributors of Temozolomide

3.5 Major Downstream Buyers of Temozolomide Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global Temozolomide Market, by Type

4.1 Global Temozolomide Value and Market Share by Type (2015-2020)

4.2 Global Temozolomide Production and Market Share by Type (2015-2020)

4.3 Global Temozolomide Value and Growth Rate by Type (2015-2020)

4.3.1 Global Temozolomide Value and Growth Rate of Temozolomide Capsules
4.3.2 Global Temozolomide Value and Growth Rate of Temozolomide Injection
4.4 Global Temozolomide Price Analysis by Type (2015-2020)

5 Temozolomide Market, by Application

5.1 Downstream Market Overview

5.2 Global Temozolomide Consumption and Market Share by Application (2015-2020)

5.3 Global Temozolomide Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global Temozolomide Consumption and Growth Rate of Hospitals (2015-2020)
5.3.2 Global Temozolomide Consumption and Growth Rate of Clinics (2015-2020)
5.3.3 Global Temozolomide Consumption and Growth Rate of Others (2015-2020)

6 Global Temozolomide Market Analysis by Regions

6.1 Global Temozolomide Sales, Revenue and Market Share by Regions

6.1.1 Global Temozolomide Sales by Regions (2015-2020)

6.1.2 Global Temozolomide Revenue by Regions (2015-2020)

6.2 North America Temozolomide Sales and Growth Rate (2015-2020)

6.3 Europe Temozolomide Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific Temozolomide Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa Temozolomide Sales and Growth Rate (2015-2020)

6.6 South America Temozolomide Sales and Growth Rate (2015-2020)

7 North America Temozolomide Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America Temozolomide Sales, Revenue and Market Share by Countries

7.2.1 North America Temozolomide Sales by Countries (2015-2020)

7.2.2 North America Temozolomide Revenue by Countries (2015-2020)

7.3 United States Temozolomide Sales and Growth Rate (2015-2020)

7.4 Canada Temozolomide Sales and Growth Rate (2015-2020)

7.5 Mexico Temozolomide Sales and Growth Rate (2015-2020)

8 Europe Temozolomide Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe Temozolomide Sales, Revenue and Market Share by Countries

8.2.1 Europe Temozolomide Sales by Countries (2015-2020)

8.2.2 Europe Temozolomide Revenue by Countries (2015-2020)

8.3 Germany Temozolomide Sales and Growth Rate (2015-2020)

8.4 UK Temozolomide Sales and Growth Rate (2015-2020)

8.5 France Temozolomide Sales and Growth Rate (2015-2020)

8.6 Italy Temozolomide Sales and Growth Rate (2015-2020)

8.7 Spain Temozolomide Sales and Growth Rate (2015-2020)

8.8 Russia Temozolomide Sales and Growth Rate (2015-2020)

9 Asia Pacific Temozolomide Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific Temozolomide Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific Temozolomide Sales by Countries (2015-2020)

9.2.2 Asia Pacific Temozolomide Revenue by Countries (2015-2020)

9.3 China Temozolomide Sales and Growth Rate (2015-2020)

9.4 Japan Temozolomide Sales and Growth Rate (2015-2020)

9.5 South Korea Temozolomide Sales and Growth Rate (2015-2020)

9.6 India Temozolomide Sales and Growth Rate (2015-2020)

9.7 Southeast Asia Temozolomide Sales and Growth Rate (2015-2020)

9.8 Australia Temozolomide Sales and Growth Rate (2015-2020)

10 Middle East and Africa Temozolomide Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa Temozolomide Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa Temozolomide Sales by Countries (2015-2020)

10.2.2 Middle East and Africa Temozolomide Revenue by Countries (2015-2020)

10.3 Saudi Arabia Temozolomide Sales and Growth Rate (2015-2020)

10.4 UAE Temozolomide Sales and Growth Rate (2015-2020)

10.5 Egypt Temozolomide Sales and Growth Rate (2015-2020)

10.6 Nigeria Temozolomide Sales and Growth Rate (2015-2020)

10.7 South Africa Temozolomide Sales and Growth Rate (2015-2020)

11 South America Temozolomide Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America Temozolomide Sales, Revenue and Market Share by Countries

11.2.1 South America Temozolomide Sales by Countries (2015-2020)

11.2.2 South America Temozolomide Revenue by Countries (2015-2020)

11.3 Brazil Temozolomide Sales and Growth Rate (2015-2020)

11.4 Argentina Temozolomide Sales and Growth Rate (2015-2020)

11.5 Columbia Temozolomide Sales and Growth Rate (2015-2020)

11.6 Chile Temozolomide Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 Tianjin Tasly
12.1.1 Tianjin Tasly Basic Information
12.1.2 Temozolomide Product Introduction
12.1.3 Tianjin Tasly Production, Value, Price, Gross Margin 2015-2020
12.2 Merck
12.2.1 Merck Basic Information
12.2.2 Temozolomide Product Introduction
12.2.3 Merck Production, Value, Price, Gross Margin 2015-2020
12.3 Jianyuan
12.3.1 Jianyuan Basic Information
12.3.2 Temozolomide Product Introduction
12.3.3 Jianyuan Production, Value, Price, Gross Margin 2015-2020
12.4 Ind-Swift
12.4.1 Ind-Swift Basic Information
12.4.2 Temozolomide Product Introduction
12.4.3 Ind-Swift Production, Value, Price, Gross Margin 2015-2020
12.5 Chongqing Lummy
12.5.1 Chongqing Lummy Basic Information
12.5.2 Temozolomide Product Introduction
12.5.3 Chongqing Lummy Production, Value, Price, Gross Margin 2015-2020
12.6 Miracalus
12.6.1 Miracalus Basic Information
12.6.2 Temozolomide Product Introduction
12.6.3 Miracalus Production, Value, Price, Gross Margin 2015-2020
12.7 Panacea
12.7.1 Panacea Basic Information
12.7.2 Temozolomide Product Introduction
12.7.3 Panacea Production, Value, Price, Gross Margin 2015-2020
12.8 Celon
12.8.1 Celon Basic Information
12.8.2 Temozolomide Product Introduction
12.8.3 Celon Production, Value, Price, Gross Margin 2015-2020
12.9 Macleods
12.9.1 Macleods Basic Information
12.9.2 Temozolomide Product Introduction
12.9.3 Macleods Production, Value, Price, Gross Margin 2015-2020
12.10 Lunarsun
12.10.1 Lunarsun Basic Information
12.10.2 Temozolomide Product Introduction
12.10.3 Lunarsun Production, Value, Price, Gross Margin 2015-2020
12.11 Natco
12.11.1 Natco Basic Information
12.11.2 Temozolomide Product Introduction
12.11.3 Natco Production, Value, Price, Gross Margin 2015-2020
12.12 Fulford
12.12.1 Fulford Basic Information
12.12.2 Temozolomide Product Introduction
12.12.3 Fulford Production, Value, Price, Gross Margin 2015-2020
12.13 Cipla
12.13.1 Cipla Basic Information
12.13.2 Temozolomide Product Introduction
12.13.3 Cipla Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global Temozolomide Market Forecast

14.1 Global Temozolomide Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 Temozolomide Capsules Market Value and Volume Forecast (2020-2025)
14.1.2 Temozolomide Injection Market Value and Volume Forecast (2020-2025)
14.2 Global Temozolomide Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 Hospitals Market Value and Volume Forecast (2020-2025)
14.2.2 Clinics Market Value and Volume Forecast (2020-2025)
14.2.3 Others Market Value and Volume Forecast (2020-2025)
14.3 Temozolomide Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment